PLC-γ1 signaling plays a subtype-specific role in postbinding cell entry of influenza A virus

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 417-424

  Zhu, Liqian ^a   Ly, Hinh ^a   Liang, Yuying ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHOLIPASE C GAMMA1; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; VIRUS ENTRY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; ENZYME ACTIVATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MEMBRANE FUSION; PHOSPHOLIPASE C GAMMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84890883532     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02591-13     Document Type: Article

References (35)

1. Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939. http://dx.doi.org/10.1038/nature08157.
2. Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647-1689. In Knipe DM, HowleyPM(ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Ison MG. 2011. Antivirals and resistance: influenza virus. Curr. Opin. Virol. 1:563-573. http://dx.doi.org/10.1016/j.coviro.2011.09.002.
4. Ludwig S. 2011. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol. Chem. 392:837-847. http://dx.doi.org/10.1515/BC.2011.121.
5. Shaw ML. 2011. The host interactome of influenza virus presents new potential targets for antiviral drugs. Rev. Med. Virol. 21:358-369. http: //dx.doi.org/10.1002/rmv.703.
6. MacArthur RD, Novak RM. 2008. Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents. Clin. Infect. Dis. 47:236-241. http://dx.doi.org/10.1086/589289.
7. Muller KH, Kakkola L, Nagaraj AS, Cheltsov AV, Anastasina M, Kainov DE. 2012. Emerging cellular targets for influenza antiviral agents. Trends Pharmacol. Sci. 33:89-99. http://dx.doi.org/10.1016/j.tips.2011.10.004.
8. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M, Elledge SJ. 2009. The IFITM proteins mediate cellular resistance to influenzaAH1N1 virus, West Nile virus, and dengue virus. Cell 139:1243- 1254. http://dx.doi.org/10.1016/j.cell.2009.12.017.
9. Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y. 2008. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454:890-893. http://dx.doi.org/10.1038/nature07151.
10. Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S, Maurer AP, Muller E, Wolff T, Rudel T, Meyer TF. 2010. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463:818-822. http: //dx.doi.org/10.1038/nature08760.
11. Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, Pache L, Shih C, Orth A, Bonamy G, Miraglia L, Ideker T, Garcia-Sastre A, Young JA, Palese P, Shaw ML, Chanda SK. 2010. Human host factors required for influenza virus replication. Nature 463:813- 817. http://dx.doi.org /10.1038/nature08699.
12. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. 2009. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255-1267. http://dx.doi.org/10 .1016/j.cell.2009.12.018.
13. Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S. 2006. Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol. 8:1336-1348. http://dx.doi.org/10.1111/j.1462-5822.2006.00713.x.
14. Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S. 2007. Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J. Virol. 81:3058-3067. http://dx.doi.org/10.1128/JVI.02082-06.
15. Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C. 2010. The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog. 6:e1001099. http://dx.doi.org /10.1371/journal.ppat.1001099.
16. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. 2006. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3- kinase signaling. Proc. Natl. Acad. Sci. U. S. A. 103:14194-14199. http: //dx.doi.org/10.1073/pnas.0606109103.
17. Kumar N, Liang Y, Parslow TG, Liang Y. 2011. Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication. J. Virol. 85:2818-2827. http://dx.doi.org/10.1128/JVI.01969-10.
18. Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y. 2011. Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses. Antimicrob. Agents Chemother. 55:5553-5559. http://dx.doi.org /10.1128/AAC.00725-11.
19. Kumar N, Xin ZT, Liang Y, Ly H, Liang Y. 2008. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82:9880- 9889. http://dx.doi.org/10.1128/JVI.00909-08.
20. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S. 2001. Influenza virus propagation is impaired by inhibition of the Raf/ MEK/ERK signalling cascade. Nat. Cell Biol. 3:301-305. http://dx.doi.org /10.1038/35060098.
21. Vines CM. 2012. Phospholipase C. Adv. Exp. Med. Biol. 740:235-254. http://dx.doi.org/10.1007/978-94-007-2888-2_10.
22. Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, Fukami K, Kataoka T, Yun S, Ryu SH. 2008. Multiple roles of phosphoinositidespecific phospholipase C isozymes. BMB Rep. 41:415-434. http://dx.doi .org/10.5483/BMBRep.2008.41.6.415.
23. Ji QS, Winnier GE, Niswender KD, Horstman D, Wisdom R, Magnuson MA, Carpenter G. 1997. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc. Natl. Acad. Sci. U. S. A. 94:2999-3003. http://dx.doi.org/10.1073 /pnas.94.7.2999.
24. Hashimoto A, Takeda K, Inaba M, Sekimata M, Kaisho T, Ikehara S, Homma Y, Akira S, Kurosaki T. 2000. Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function. J. Immunol. 165:1738-1742.
25. Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ, Ihle JN. 2000. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25-35. http://dx.doi.org/10.1016 /S1074-7613(00)00005-4.
26. Eierhoff T, Ludwig S, Ehrhardt C. 2009. The influenza A virus matrix protein as a marker to monitor initial virus internalisation. Biol. Chem. 390:509-515. http://dx.doi.org/10.1515/BC.2009.053.
27. Osterlund P, Strengell M, Sarin LP, Poranen MM, Fagerlund R, Melen K, Julkunen I. 2012. Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry. J. Virol. 86:11183-11193. http://dx.doi.org/10.1128/JVI.01050-12.
28. Goodman AG, Smith JA, Balachandran S, Perwitasari O, Proll SC, Thomas MJ, Korth MJ, Barber GN, Schiff LA, Katze MG. 2007. The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J. Virol. 81:2221-2230. http://dx.doi.org/10.1128/JVI.02151-06.
29. Osherov N, Gazit A, Gilon C, Levitzki A. 1993. Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J. Biol. Chem. 268:11134-11142.
30. Fan K, Jia Y, Wang S, Li H, Wu D, Wang G, Chen JL. 2012. Role of Itk signalling in the interaction between influenza A virus and T-cells. J. Gen. Virol. 93:987-997. http://dx.doi.org/10.1099/vir.0.041228-0.
31. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, Garcia-Sastre A, Rottier PJ, de Haan CA. 2011. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7:e1001329. http://dx.doi.org/10.1371 /journal.ppat.1001329.
32. Luo M. 2012. Influenza virus entry. Adv. Exp. Med. Biol. 726:201-221. http://dx.doi.org/10.1007/978-1-4614-0980-9_9.
33. Alvi F, Idkowiak-Baldys J, Baldys A, Raymond JR, Hannun YA. 2007. Regulation of membrane trafficking and endocytosis by protein kinase C: emerging role of the pericentrion, a novel protein kinase C-dependent subset of recycling endosomes. Cell. Mol. Life Sci. 64:263-270. http://dx .doi.org/10.1007/s00018-006-6363-5.
34. Jonges M, Liu WM, van der Vries E, Jacobi R, Pronk I, Boog C, Koopmans M, Meijer A, Soethout E. 2010. Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling. J. Clin. Microbiol. 48:928-940. http://dx.doi.org/10.1128 /JCM.02045-09.
35. Lee SM, Yen HL. 2012. Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection. Antiviral Res. 96:391-404. http://dx.doi.org/10.1016/j.antiviral.2012.09.013.